Diseases of Thyroid
The authors conducted a review of the most prevalent skin manifestations associated with the thyroid and its functions. Cutaneous diseases more often related to hyperthyroidism and hypothyroidism, and the structural changes of the thyroid gland are discussed separately. The pathogenesis, clinical presentation, investigative examinations, and treatment of thyroid-related cutaneous disease are described.
KeywordsThyroid Hyperthyroidism Hypothyroidism Mucopolysaccharides Textural alterations Pretibial myxedema Graves’ ophthalmopathy Thyroid acropachy Generalized myxedema Thyroglossal duct cyst Cutaneous metastases
Manifests as skin changes displaying violet spots on the trunk and limbs, which can be highlighted by cold temperature.
The condition when an individual sees two images of the same object.
Components of the connective tissue. They represent 30% of the body’s organic material and can exist as different types, such as chondroitin sulfate for cartilage, bone, or cornea; dermatan sulfate for the dermis and the tendons; and heparan sulfate for the liver, lungs, and aorta.
A biopolymer made of the glucuronic acid and N-acetylglucosamine. With a viscous texture, it exists in the synovial fluid, the vitreous humor, and the connective tissue of numerous organisms, being an important glycosaminoglycan in articulation composition.
The accumulation of interstitial fluid rich in proteins of high molecular weight.
The abnormal growth of the tongue so that it reaches a size larger than the one allowed by the buccal cavity, resulting in impaired phonation and respiratory, suction, and/or swallow function.
An extracorporeal process by which the blood collected from a patient is separated into its plasma and cell element compounds.
Proptosis is characterized by a displacement of the eyeball to the front of one eye, or both eyes.
RET proto-oncogene activating mutations may result in the development of the thyroid medullary carcinoma. Its research study is useful for the genetic tracking of thyroid medullary carcinoma.
Radioactive iodine treats hyperthyroidism by gradually shrinking the thyroid, ultimately destroying the gland.
A monoclonal chimeric antibody (murine/human) against an antigen that is the protein of the cell surface, CD20
A hormone that plays a role in several body functions, including growth and metabolism.
T3 and T4 (thyroxine) are hormones produced by the thyroid gland. They help to control the rate at which the body uses energy, and are regulated by a feedback system.
TSH stimulates the production and release of T4 (primarily) and T3. As necessary, T4 is converted to T3 by the liver and other tissues.
TTF-1 regulates the transcription of the specific genes of the thyroid, the lung, and the diencephalon. It is used in anatomic pathology as a marker to determine whether a tumor has its origin in the lung or the thyroid.
- 5.World Health Organization/International Council for the Control of the Iodine Deficiency Disorders/United Nations Childrens Fund (WHO/ICCIDD/UNICEF). Assessment of the iodine deficiency disorders and monitoring their elimination. WHO/NHD/01.1. Geneva: World Health Organization; 2001.Google Scholar
- 9.Burman K. Chapter 41. Hyperthyroidism. In: Becker KA, editor. Principles and practice of endocrinology and metabolism. 2nd ed. Philadelphia: J.B. Lippincott; 1995. p. 367–85.Google Scholar
- 22.Fung S, Malhotra R, Selva D. Thyroid orbitopathy. Aust Fam Physician. 2003;31:615–20.Google Scholar
- 23.Mafee MF. Orbit: embryology, anatomy and pathology. In: Som PM, Curtin HD, editors. Head and neck imaging. 4th ed. St Louis: Mosby; 2003. p. 529–654.Google Scholar
- 34.Fatourechi V. Pretibial myxedema – pathophysiology and treatment options. Am J Clin Dermatol. 2005;6(5):295–309.Google Scholar
- 49.Weismann K, Graham R. Systemic disease and the skin. In: Champion R, Burton J, Burns D, Breathnach S, editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science; 1998. p. 2703–57.Google Scholar
- 52.Santos HMGP, Vargas PR, Carvalho TM. Manual de normas técnicas e rotinas operacionais do programa nacional de triagem neonatal. Brasília. Ministério da Saúde. Secretaria de Assistência à Saúde Coordenação-Geral de Atenção Especializada. 1st ed. Brasília; 2002.Google Scholar
- 55.Târcoveanu E, Niculescu D, Cotea E, et al. Thyreoglossal duct cyst. J Chir. 2009;5(1):45–51.Google Scholar
- 56.Pribitkin AE, Friedman OE. Papillary carcinoma in a tyroglossal duct remnant. Arch Otolaryngol Head Neack Surg. 2002;12.Google Scholar
- 65.Aghasi MR, Valizadeh N, Soltani S. A 64 year-old female with scalp metastasis of papillary thyroid cancer. Indian J Endocr Metab. 2011;15(S2):S136–7.Google Scholar
- 67.Tamiolakis D, Antoniou C, Venizelos J, et al. Papillary thyroid carcinoma metastasis most probably due to fine needle aspiration biopsy. A case report. Acta Dermatoven APA. 2006;15:169–72.Google Scholar
- 68.Bruglia M, Palmonella G, Silvetti F, et al. Skin and thigh muscle metastasis from papillary thyroid cancer. Singap Med J. 2009;50:e61–4.Google Scholar
- 69.Cohen PR. Metastatic papillary thyroid carcinoma to the nose: report and review of cutaneous metastases of papillary thyroid cancer. Dermatol Pract Conceptual. 2015;5(4):7.Google Scholar